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Abstract
The Effects of E-Cigarette Exposure on the Peripheral Vasculature
Christopher Pitzer
E-cigarettes have emerged as popular alternatives to traditional smoking, partially because of
efforts of manufacturers to portray them as safe. Recent studies have cast doubt on claims of
safety, our lab has published data showing a significant impairment in endothelium-dependent
dilation with chronic exposure, however the acute temporal effects and mechanisms involved
with E-cigarette exposure on the vasculature are still poorly characterized. This study uses an
intravital microscopy approach to evaluate the effects of acute time course changes following
E-cigarette vapor exposure on second-order arterioles in the gluteus maximus muscle of mice.
We hypothesized that endothelial impairment would be observed with a single E-cigarette
exposure. C57BL/6 mice were anesthetized and a portion of the gluteus maximus muscle was
externalized to allow visualization of second order arterioles. Arteriolar tone was monitored for
up to 120-minutes in one study to determine the effects of E-cigarette exposure. In a separate
study, vascular function was assessed by dilation to acetylcholine 50 minutes after exposure to
a single 5-minute (10 puff) exposure to E-cigarette vapor. Significant vasoconstriction occurred
in E-cigarette exposed animals with or without nicotine using 50:50 vegetable
glycerin/propylene glycol (VG/PG-18 and VG/PG-0, respectively, p<0.05), as well as in animals
exposed to 100% PG with no nicotine (PG-0) and 100% VG with no nicotine (VG-0). E-cigarette
responses were similar to animals exposed to traditional tobacco-based 3R4F reference
cigarette (3R4F). No significant differences in vessel response to acetylcholine pre- vs. postexposure were generally found; except with VG/PG-18, which showed significant increase in
acetylcholine curve slope after vaping. Assessment of growth factor and cytokines response
following chronic (8-month) exposure to E-cigarette exposure was obtained from a separate
study which we have previously show impaired vascular function (Olfert et al. 2018). Cytokine
quantification was performed using a multiplex kit from Meso-Scale Discovery (Rockville, MD,
US) on homogenates of lung, gastrocnemius muscle, serum and bronchoalveolar lavage fluid
(BALF) in C57BL/6 mice exposed to filtered room air (AIR), 3R4F cigarette, and Cappuccinoflavored E-cigarette vapor (E-CIG, 50:50 VG/PG). IL-6 in the serum of E-CIG animals was
significantly lower than AIR animals (P<0.05). VEGF tended to be lower in BALF and lungs of ECIG animals relative to air controls. Granulocyte-macrophage colony stimulating factor (GMCSF) also tended to be lower in E-CIG animals relative to 3R4F and AIR animals. Collectively, our
data shows that acute E-cigarette exposure causes peripheral constriction (~20%) of blood
vessels independent of nicotine and suggests that the base components of E-liquid cause
vasoconstriction to a similar degree. Endothelial dilatory capacity is largely unaffected by Ecigarette exposure after 1-hour following a single acute exposure. Chronic E-cigarette exposure
alters the expression of IL-6 in the serum and may affect expression of VEGF in the lungs and
BALF and GM-CSF expression in the lungs. Taken together these data suggest that vaping has
acute effects on the basal blood vessel tone that is similar to traditional cigarettes, suggesting
the chronic E-cigarette use is likely to produce long-term vascular health consequences similar
to that observed with cigarette smoking.
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Chapter 1: Background and Significance
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1.1 Overview of E-cigarette Function and Potential Toxicities
Since they first appeared on the US market in 2006, E-cigarettes have evolved from
disposable “cig-a-like” devices to refillable “tank style” devices (U.S. Food & Drug
Administration, 2016) (Figure 2.1). The evolution of E-cigarette products now includes larger
“mods” devices with variable temperature, resistance and voltage settings. E-cigars and E-pipes
have recently appeared in US markets but despite different appearances, function in the same
manner as other E-cigarettes.
Despite the differences in appearance all E-cigarettes operate by heating a “base”
mixture of propylene glycol and vegetable glycerin, that also contains flavoring and in most
cases nicotine, to the point of evaporation allowing the user to inhale the aerosol (Ikonomidis
et al., 2018). Different refill liquids for E-cigarettes are known to contain flavorings that upon
heating can generate potentially toxic compounds, many of which are cytotoxic to endothelial
cells(e.g. cinnamaldehyde) (Behar et al., 2014; P. W. Clapp & Jaspers, 2017). Many devices offer
variable voltage or temperature settings which may change the composition of the aerosol with
higher voltages generally resulting in higher concentrations of breakdown products (Kosmider
et al., 2014).
It is believed that the breakdown of the base solvents during heating leads to the
generation of carbonyl compounds that are known to be carcinogenic (Cassee et al., 2008;
Tyihák, Bocsi, Timár, Rácz, & Szende, 2001) It is also possible that with repeated heating,
particles of metal from the atomizer become aerosolized and inhaled (Hess et al., 2017; Nayir,
Karacabey, Kirca, & Ozdogan, 2016). E-cigarette liquids themselves have also been shown to

2

Figure 1.1: Image from CDC Surgeon General Report (Center for Disease Control and
Prevention, 2011) depicting various E-cigarette devices of different generations.

contain nitrosamines, compounds that are inflammatory and carcinogenic (Farsalinos, Gillman,
Poulas, & Voudris, 2015; H. J. Kim & Shin, 2013). Studies using cell culture techniques have
shown that exposure to E-cigarette aerosol extract can suppress antioxidant defenses and
increase oxidative DNA damage (Ganapathy et al., 2017). The decrease in antioxidant capacity
and induction of DNA damage may be a potential mechanism for tumorigenesis.
E-cigarette liquid has also been shown to increase the rate of viral infection of cells that
have been exposed to it (Wu, Jiang, Minor, & Chu, 2014). Decreased immunity in the airways
may lead to increased infection rates in the upper respiratory tract. This process is likely
mediated through altered function of neutrophils, which have been shown to be activated in
the lungs in response to E-cigarette vapor exposure (Hwang et al., 2016) as well as increased
secretion of proinflammatory cytokines (Higham et al., 2016).
3

An emerging body of evidence has shown that E-cigarette liquids are cytotoxic to
human vascular endothelial cells (Anderson, Majeste, Hanus, & Wang, 2016; Putzhammer et al.,
2016). This toxicity is a likely mechanism of decreased endothelium dependent dilation seen
with E-cigarette exposure studies (Carnevale et al., 2016; Olfert et al., 2018). It is also likely that
endothelial cell toxicity can lead to the development of atherosclerosis by increasing
endothelial permeability. One recent study shows that exposing human vascular endothelial
cells to E-cigarette aerosol extract results in both apoptosis and programmed necrosis
pathways leading to increases in DNA fragmentation (Anderson et al., 2016). These changes
were resolved upon treatment of cells with antioxidants (Anderson et al., 2016), suggesting that
oxidative damage to endothelial cells is likely to lead to vascular impairment and an increased
risk for CVD (Qasim, Karim, Rivera, Khasawneh, & Alshbool, 2017).

1.2 Comparison of toxicity of E-cigarettes and traditional cigarettes
Determining the relative toxicity of E-cigarettes compared to traditional cigarettes has
been a recent focus in the literature. Effects of E-cigarettes and traditional cigarettes on air
quality is emerging as a public health concern. It is well documented that the vapor produced
by E-cigarettes is less complex than smoke from combustible cigarettes (Carnevale et al., 2016;
P. W. Clapp & Jaspers, 2017). Decreased complexity does not simply equate to decreased
toxicity however, as some compounds linked to E-cigarette vapor have been shown to be
cytotoxic (Behar et al., 2014; Farsalinos, Gillman, et al., 2015). Other studies using ultra-high
performance liquid chromatography tandem mass spectrometry (UHPLC-MS) methods have

4

found concentrations of chemicals known to be corrosive or toxic in vapor extracts, these
chemicals were not present in the liquid before vaporizing (Higham et al., 2016). Recent data
has also shown that E-cigarette vapor exposure is linked to development of a COPD phenotype
in mice in a nicotine dependent manner (Garcia-Arcos et al., 2016). This is likely due to the
interactions of constituents of E-cig vapor with neutrophils present in the lungs (Higham et al.,
2016).
The presence of formaldehyde and acetaldehyde has been demonstrated in both the
smoke of traditional cigarettes and in E-cigarette vapor (Kosmider et al., 2014; Ogunwale et al.,
2017; Wang et al., 2009). The relative quantities of toxic aldehydes in each remains
controversial. While studies of early generation E-cigarette products showed greatly decreased
aldehyde concentrations (Ogunwale et al., 2017), studies of newer variable temperature and
voltage devices show that levels of aldehydes approach those of traditional cigarettes
(Ogunwale et al., 2017). An argument proposed by Jensen et al. claims that a large portion of
aldehydes present in E-cigarette vapor are “hidden” as aldehyde containing hemiacetals, which
are broken down to formaldehyde in the body but undetected by traditional aldehyde
detecting methods (Seifter, 2014). Experimental confirmation of this hypothesis is warranted,
as aldehydes are highly toxic and high levels found in E-cigarette vapor would be a public health
concern.
Proteomic analysis has shown that there are biological effects of aldehydes in the lungs
of E-cigarette users. Reidel et al. have shown that E-cigarette exposure significantly increases
expression of aldehyde detoxifying enzymes, oxidative stress response proteins, and matrix
metalloproteinase-9 (MMP-9) in the sputum of E-cigarette users (Reidel et al., 2017; Reidel et
5

al., 2010). The levels of these enzymes were comparable to those found in cigarette smokers,
possibly indicating a nonlinear toxicity of reactive carbonyls in the lungs (if levels of the
aldehydes are indeed lower in E-cigarettes). The other elevated proteins found in the
secretomes of subjects in these studies are also important, oxidative stress as well as increased
levels of MMP-9 are known to exacerbate development of the COPD phenotype (Mercer et al.,
2005).
From a vascular perspective, the amount of oxidative stress E-cigarettes cause is
somewhat controversial. Ikonomidis et al. have shown that arterial stiffness and markers of
oxidative stress are decreased with use of E-cigarettes when compared to traditional cigarettes
(Ikonomidis et al., 2018). Other studies have however shown that particulate matter of similar
size to that found in E-cigarettes can cause rapid and lasting cardiovascular toxicity via oxidative
mechanisms (Brook et al., 2002; Kampfrath et al., 2011).
Analysis of particulate matter emitted from E-cigarettes has shown that the number of
particles inhaled from a puff of an E-cigarette are approximately equal to, if not slightly greater
than those of a traditional cigarette (Ingebrethsen, Cole, & Alderman, 2012; Thorne et al.,
2016). There is less consensus in determining the mutagenic potential of those particles.
Thorne et al. have shown that E-cigarette aerosol is not mutagenic to two different strains of
Salmonella typhimurium (Thorne et al., 2016). This contradicts the findings of Ganapathy, who
found a potential mechanism of mutagenesis via suppression of antioxidant defenses and
induction of oxidative DNA damage to cultured human mouth and lung epithelial cells
(Ganapathy et al., 2017). These results, while interesting, may not be appropriate for
determining mutagenic capacity, as Ganapathy et al. (while using human cells) did not attempt
6

to match for an average exposure of those cells in realistic use. The concentrations these cells
were exposed to may have been higher doses than mouth or lung epithelium would realistically
be exposed to even with regular use. The overall mutagenic capacity of E-cigarettes in real use
situations is still unclear, and thus real comparisons to traditional cigarettes is still poorly
understood.
Studies comparing the effects of E-cigarette and traditional cigarette on indoor air
quality have also yielded conflicting results. McAuley et al. found no immediate risk to human
health from E-cigarette emissions in their study which used a 40-cubic meter room as an
exposure chamber while testing for compounds traditionally found in secondhand smoke
(McAuley, Hopke, Zhao, & Babaian, 2012). In a study with a 45-cubic meter exposure chamber,
Schober et al. found significantly elevated levels of 1,2-propanediol, nicotine, glycerin and
aluminum. 1,2-propanediol is of particular concern in this study as particles from secondhand
exposure may deposit in the lungs, where irritation may occur (Schober et al., 2014). Another
study, which took air samples before and during an E-cigarette convention (room volume 4023
cubic meters) found 125-330 times higher levels of particulate matter smaller than 2.5
micrometers during the event (Soule et al., 2018). Inhalation of particulate matter of this size
distribution has been linked to acute cardiovascular dysfunction (Brook et al., 2002). Overall,
the effects of secondhand E-cigarette exposure poorly characterized and more research is
warranted to determine safety and inform policy decisions.
Because of marketing campaigns suggesting that E-cigarettes are safe, or safer, relative
to combustible cigarettes, and recommendations of other governments to reduce harm by
replacing cigarettes with E-cigarettes, the use of E-cigarettes as a smoking cessation aid has
7

been suggested (Brown, Beard, Kotz, Michie, & West, 2014; Christopher Bullen et al., 2013;
Orellana-Barrios, Payne, Medrano-Juarez, Yang, & Nugent, 2016). E-cigarettes are not, however
approved as cessation aids in the United States by the FDA, due largerly to a lack of literature
definitively illustrating E-cigarettes as safer alternatives and the publication of studies showing
that E-cigarettes are likely minimally effective in promoting cessation (Brown et al., 2014;
Caponnetto et al., 2013; Orellana-Barrios et al., 2016). Bullen et al. have shown that
participants reported a significant decrease in satisfaction using E-cigarettes compared to
traditional cigarettes (C. Bullen et al., 2010). This is an important result, as behavioral analysis
of individuals who smoke, even those who desire to quit, report satisfaction with the act of
handling and lighting traditional cigarettes (Jarvis, 2004). The absence of the rituals (handling
boxes, lighting the cigarette, etc.) that cigarette smokers have become attached to may
decrease the efficacy of E-cigarettes as smoking cessation tools.
Overall, the comparison of traditional combustible cigarettes to E-cigarettes is not likely
an “apples to apples” comparison. The variability of E-cigarette device settings as well as the
number of brands, flavorings and base liquid mixtures presents a degree of difficulty in
comparing E-cigarettes to traditional cigarettes. Studying the biological effects of E-cigarettes is
also difficult since the effects of each variable component of E-cigarettes on vapor content and
biological activity is poorly understood. E-cigarettes are also not recommended as
replacements for traditional cigarettes because there is a lack of evidence that they are
effective cessation tools, some studies even report a “dual use” effect where users maintain
daily cigarette intake and use E-cigarettes also (Correa et al., 2018; Orellana-Barrios et al.,
2016).
8

1.3 Effects of E-cigarettes on Immune System Function and Cytokine Expression.
The relative newness of E-cigarettes (<12 years) makes the study of long-term effects on
humans difficult, in part, because smoking-related heart disease and COPD is often found only
after several decades of exposure. This has made animal models and cell culture experiments
increasingly important to gain early insight in determining potential risks with chronic ECigarette before decades must pass for us to understand the consequences vaping of humans.
Because the lungs are the primary site of contact, studies of pulmonary immunity have been a
recent priority of the literature (Hwang et al., 2016; Sussan et al., 2015; Wu et al., 2014). Cell
culture studies are also valuable for this process also as they allow for precise control of
exposure dose and monitoring of the response of individual cell populations.
Pulmonary injury is a major concern of current E-cigarette research. Recent data has
linked E-cigarette exposure to an increase in Th2 cytokines (Interleukins 4,5,10 and 13 (Barnes,
2001)) in the lungs. Th2 cytokines are thought to be responsible for sensitization of the lungs
and a potential cause of asthma (P. W. Clapp & Jaspers, 2017). Development of asthma is of
particular concern among younger users, the US Surgeon General reports that use of Ecigarettes among middle school students is approximately equal to use among adults over 25
(US Department of Health and Human Services, 2017). E-cigarette exposure in mice has also
been shown to induce a COPD phenotype in a nicotine-dependent manner (Garcia-Arcos et al.,
2016). The progression of COPD has been shown to worsen through increases in proinflammatory cytokines, mostly coming from neutrophils (neutrophil associated cytokines
include IL-8, leukotriene B4 and tumor-necrosis-factor-alpha, TNF-α) (Reid & Sallenave, 2003).
E-cigarette use has also been shown to increase presence of neutrophils in the lung (Boris
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Reidel, Giorgia Radicioni, Phillip Clapp, Amina A Ford, Sabri Abdelwahab, Meghan E Rebuli,
Prashamsha Haridass, Neil E Alexis & Kesimer, 2010; Hwang et al., 2016) and increase the
inflammatory response of the neutrophils (Higham et al., 2016) pointing to a possible concern
of COPD development in chronic users.
Altered immune cell expression in the lungs also results in altered immune system
efficiency. Exposure to E-cigarette exposure in mice has been shown to increase presence of
bacterial colonies (Hwang et al., 2016). This is likely due, at least in part, to a decrease in
phagocytosis of macrophages caused by E-cigarette exposure (Sussan et al., 2015). Studies have
also shown increased rates, duration and severity of viral infection upon exposure to E-cigarette
vapor (Sussan et al., 2015; Wu et al., 2014). Increased infection and duration may also play a
role in the pathogenesis of the COPD phenotype, increasing neutrophil presence in the lung
(and as described above has been linked to decreased activity of NK cells (PRIETO et al., 2001)
as well as decreased phagocytic activity (Drannik et al., 2004)). This dysfunction in the immune
system may lead to exacerbations of COPD, leading to reductions in lung function which is an
important cause of death of patients with COPD (Hoenderdos & Condliffe, 2013).
While there is little data available in the context of E-cigarettes’ effect on cytokine
expression, the effects of cigarettes are well characterized. Likely the first proinflammatory
mechanism to be activated upon inhalation of cigarette smoke is the NF-κB pathway. NF-κB has
been shown to increase the release of IL-8 as well as TNF-α (Yang et al., 2006). While the direct
effects of E-cigarettes on NF-κB have yet to be directly studied, chemicals commonly used to
flavor E-cigarettes have been shown to significantly increase IL-8 production in cultured
monocytic cell lines (Muthumalage et al., 2018). This finding is interesting because the isolated
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flavoring chemicals were used rather than whole base liquids, meaning the increases in IL-8
happen independently of nicotine concentration. NF-κB has also been shown to modify histone
de-acetylases after transcription (Yang et al., 2006), this is likely to increase the period of time
that proinflammatory genes remain upregulated after exposure to inflammatory stimuli. While
it is likely that E-cigarette flavorings increase IL-8 secretion through an NF-κB dependent
mechanism this has yet to have been experimentally confirmed, further study is necessary to
determine the effects of E-cigarettes on NF-κB and the cytokines that it promotes.
One of the most potent inflammatory mediators in acute cigarette exposure is TNF-α.
Churg et al. have shown that TNF- α is necessary for the alteration of gene expression and onset
of tissue breakdown associated with acute cigarette exposure (Churg, Dai, Tai, Xie, & Wright,
2002). TNF- α has also been shown to increase levels of membrane metalloproteinase enzymes,
which are known to cause vascular remodeling and affect wound healing (Han, Tuan, Wu,
Hughes, & Garner, 2001). Caspase enzymes, which have been shown to increase levels of
endothelial apoptosis, also have been shown to increase with elevated levels of TNF- α (Csiszar,
Ungvari, Koller, Edwards, & Kaley, 2004). It is important to note that endothelial cell apoptosis
is likely to increase systemic circulation of IL-8 which is a potent neutrophil chemotactic factor,
and since neutrophils can secrete TNF- α a positive feedback loop consisting of neutrophilia,
TNF- α secretion, caspase activation and IL-8 secretion is not difficult to imagine regarding
cigarette and E-cigarette exposure.
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Figure 1.2 shows a potential mechanism of positive feedback following E-cigarette exposure. In
this mechanism E-cigarette exposure drives neutrophil infiltration of the lungs and stimulates
secretion of TNF-α, which through a caspase enzyme mediated mechanism drives endothelial
cell apoptosis and causes increased secretion of IL-8. IL-8 drives further neutrophilia of the lung
by its action as a chemotactic factor.

1.4 E-cigarette and tobacco use and regulations
In 2016 the FDA expanded its definition of “tobacco products” to include E-cigarettes,
liquids, and atomizers (U.S. Food & Drug Administration, 2016). Emerging concerns about the
quality and manufacturing of E-cigarettes and E-liquids has led to manufacturing regulations of
E-cigarette products effective beginning August 2018, as well as age restrictions to purchasing
E-cigarette products (U.S. Food & Drug Administration, 2016).
Marketing campaigns by E-cig manufacturers portray their devices as “safe alternatives”
to traditional cigarettes, but the good news is that a majority (72%) of Americans recently

12

surveyed believe that E-cigarettes will harm the health of users (“American S ’ Perspectives on
E-Cigarettes,” 2015). When considering the public opinions surrounding E-cigarettes, it is not
surprising that 5 US states and over 400 counties have laws prohibiting the use of E-cigarettes
indoors and other places where traditional smoking is prohibited (“American S ’ Perspectives on
E-Cigarettes,” 2015). Other public health concerns surrounding E-cigarettes are also present; for
example studies have shown that inaccurate nicotine content has been found with E-liquid
manufacturing (Buettner-Schmidt, Miller, & Balasubramanian, 2016; Castranova, Asgharian,
Sayre, Virginia, & Carolina, 2016). Childproof containers are also infrequently used to contain Eliquid, this is of concern because fatal amounts of nicotine may be absorbed through the mouth
or skin of a child (Buettner-Schmidt et al., 2016). One such death in the United states, in 2014,
has prompted several states to adopt legislation requiring manufacturers to use childproof
containers package their products (Frey & Tilburg, 2016).

1.5 Effects of E-cigarettes and traditional cigarettes on vascular reactivity
Cigarette smoke has long been associated with vascular dysfunction (Lehr, 2000), the
superoxide anion produced while smoking is thought to play a role in decreasing nitric oxide
(NO) availability and damaging the endothelial cells that produce NO (Raij, DeMaster, & Jaimes,
2001). One of the most common means of testing endothelial function is testing reactivity to
acetylcholine. Acetylcholine interacts with soluble guanylyl cyclase to increase concentration of
cyclic guanylyl monophosphate (cGMP); increases in cGMP causes stimulation of endothelial
nitric oxide synthase (eNOS) and through a calcium dependent mechanism causes release of
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endothelium derived relaxing factors (EDRF) that cause relaxation of vascular smooth muscle
cells(Thomsen, Rubin, & Lauritzen, 2000).
Reactivity of blood vessels to acetylcholine is often used as a measure of vascular health
(Figure 2.3). Lekakis et al. have shown that acute cigarette smoke exposure alters endothelial
function in humans (Lekakis et al., 1997). While it is known that conditions such as hypoxia and
inflammation may decrease the ability of the endothelium to produce NO (B. R. Clapp et al.,
2004; Jeremy, Yim, Wan, & Angelini, 2002), there are few studies detailing the effects of acute
E-cigarette exposure on endothelial function. It is however known that pulmonary exposure to
cigarette smoke increases activity of nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase (an enzyme responsible for the generation of free radicals) (M. Kim, Han, & Lee, 2014).
NADPH oxidase is responsible for the generation of the superoxide ion, a free radical
that has been shown to preferentially react with nitric oxide to form peroxynitrite (Beckman &
Koppenol, 1996). Excess peroxynitrite in the vasculature is associated with a decrease in
dimerization of eNOS and a shift towards the production peroxynitrite by the eNOS enzyme
itself in a process called eNOS uncoupling (Förstermann & Münzel, 2006). eNOS uncoupling is
likely caused by the oxidation of tetrahydrobiopterin (BH4), a cofactor of eNOS that causes
dimerization. BH4 is oxidized by peroxynitrite quickly in the endothelial cells (Kuzkaya,
Weissmann, Harrison, & Dikalov, 2003). Asano et al. have shown that NADPH oxidase activity
(and presumably endothelial uncoupling) is significantly elevated upon exposure to nicotine and
tar free cigarette smoke extract (Asano et al., 2012). While nicotine is not required for NADPH
oxidase activity to be upregulated there is also an experimentally determined role of nicotine in
this pathway; fang et al. have shown that inhibition of NADPH oxidase improves vascular
14

reactivity with chronic intraperitoneal injections of nicotine (Fang, 2006). These results are
important when considering the potential impact of E-cigarettes on vascular reactivity, while
nicotine may play a role in exacerbating NADPH oxidase activity, particulate matter emitted
from E-cigarettes is also likely to play a role in NADPH oxidase upregulation and therefore
vascular dysfunction (Kampfrath et al., 2011). This implies that E-cigarettes containing zero
nicotine are also likely to decrease vascular reactivity.
Shown in Figure 2.3, calcium-dependent and -independent mechanisms of NO synthesis
by the endothelium. The effects on this pathway as described above relate only to the calcium
dependent mechanisms. The rightmost depiction in the figure illustrates the mechanism of
vascular smooth muscle constriction to acetylcholine when the endothelium is damaged.

Figure 1.3 shows the calcium dependent pathway of NO synthesis (the pathway through
which acetylcholine acts), the calcium independent pathway of NO synthesis and the
mechanism by which acetylcholine can cause vasoconstriction when vascular endothelium is
damaged.
15

The calcium-independent pathway of NO synthesis involves the distension of the
glycocalyx that lines the luminal surface of endothelial cells. As shown in Figure 2.3 the
distension of glycocalyx branches causes activation of eNOS independently of calmodulin in the
endothelium. Blood viscosity is important in the generation of NO in this manner and cigarette
smoking has been shown to increase blood viscosity and decrease the ability of blood to exert
sufficient shear stress on the glycocalyx to stimulate eNOS(Original Article, 2011). The effects of
cigarette smoking on blood viscosity are likely due to increases in fibrinogen (Haustein, Krause,
Haustein, Rasmussen, & Cort, 2002). The effects of E-cigarettes on blood viscosity have yet to
be studied, further research is needed to determine if E-cigarette exposure will affect eNOS
activity in this way.
Apoptosis of endothelial cells is another potential mechanism of dysfunction, especially
in the context of chronic use of cigarettes and E-cigarettes; endothelial cells can undergo a
specific type of apoptosis called anoikis, in which the cells detach from the extracellular matrix
and enter circulation (Boos, Balakrishnan, Blann, & Lip, 2008). Raveendran et al. showed that
priming endothelial cells to secrete NO had a protective effect on the cells upon exposure to
cigarette smoke (Raveendran et al., 2005). This means that oxidative damage to endothelial
cells by cigarettes or E-cigarettes may be prevented at the expense of NO bioavailability in vivo.
Further oxidative stress on the endothelium may occur as the neutrophil response to Ecigarettes occurs, proinflammatory cytokines secreted by neutrophils may also effect NO
bioavailability (B. R. Clapp et al., 2004) and endothelial cell apoptosis.
Vasomotor impairment caused by endothelial dysfunction is a precursor to CVD,
cigarette smoke has been shown to cause endothelial dysfunction and vasomotor impairment
16

(Celermajer et al., 1993; Raij et al., 2001; Rubenstein, Yong, Rennard, & Mayhan, 1991; With &
Artery, 2018). The effects of E-cigarette exposure on the endothelium is not as well
characterized, however a recent study from our laboratory has found chronic exposure to vapor
has been shown to decrease endothelial dependent dilation in the aorta of mice (Olfert et al.,
2018). This is important to consider when evaluating the safety of E-cigarettes as it implies a
state of increased oxidative stress on the vasculature, which is known to decrease endothelial
function, and lead to disease states such as atherosclerosis, coronary artery disease and heart
failure (Anderson et al., 2016; B. R. Clapp et al., 2004; Kitta et al., 2009). The acute and chronic
effects of E-cigarettes on vascular structure and function need further study, particularly
toward the risk endothelial cells pose for development of CVD with chronic use.

1.6 Overview and History of Intravital Microscopy to Study the Vasculature and Effects of
Smoking
Intravital microscopy is a procedure in which a living system is visualized while the
organism being studied is still alive. These techniques have long been used to characterize the
effects of toxicants on the vasculature and on the circulating immune cells. The body of
literature concerning traditional cigarettes and isolated nicotine from an intravital perspective
is quite robust (Álvarez et al., 2004; Kubes, Suzuki, & Granger, 1991; Lehr, 2000; Lehr, Frei, &
Arfors, 1994; W G Mayhan & Sharpe, 1998; William G. Mayhan, 1999; Rubenstein et al., 1991),
there is however minimal data concerning E-cigarettes in this capacity.
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By the 1960’s scientists established a link between smoking and heart disease (William,
Thomas, Sandra, Doyle, & Dawber, 1964). To address this issue and elucidate mechanisms,
intravital studies became a popular means of visualizing the vasculature, and the cells it
contains. Through these studies, investigators found a decrease in endothelium dependent
dilation (Ambrose & Barua, 2004; Anderson et al., 2016; Raij et al., 2001; Rubenstein et al.,
1991), as well as an increase in leukocyte adhesion and rolling along venules (“CIGARETTE
SMOKE ELICITS LEUKOCYTE ADHESION TO,” n.d.). Leukocyte adhesion and rolling is an
important part of the inflammation response, in response to inflammatory stimuli endothelial
cells will express chemoattractant molecules on their surface. This allows the leukocytes to
follow the chemoattractant molecules to the site of cellular injury where they can exit the
vasculature and act inside the inflamed tissue (Yong, Zheng, & Linthicum, 1997). Leukocyte
adhesion and rolling is shown to occur in both arterioles (Álvarez et al., 2004) and in venules
(Kubes et al., 1991; Lehr et al., 1994; Yong et al., 1997). Intravital studies also have shown that
the increased leukocyte adhesion and rolling is likely due to oxidative mechanisms as treatment
with superoxide dismutase( Reactive oxygen Species & Hepatocytes, 2004) and vitamin C (Lehr
et al., 1994) before exposure to cigarette smoke decreases leukocyte adhesion and rolling.
While there is currently no published data (that we are aware of) detailing the effects of
E-cigarettes from an intravital perspective, there is available data concerning the effects of
nicotine. Most intravital studies focusing on nicotine use an IV administration paradigm, this
allows the concentration of nicotine in the blood to be precisely controlled. A study by Mayhan
showed an increase in constriction to norepinephrine in vivo using this paradigm (William G.
Mayhan, 1999). The results of this study are particularly important, as nicotine is known to have
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sympathomimetic effects, some mediated through norepinephrine, and the increased levels of
constriction may play a role in nicotine-induced pathogenesis of cardiovascular disease.
The effects of nicotine on basal vascular tone are somewhat controversial. Some studies
have found that nicotine is vasodilatory (Hilton, 1954) while others have shown no effect on
vascular tone (Odginai Article, 1992). Black, et al. have shown that nicotine increases the
vasoconstriction response of the peripheral vasculature this effect may be partially responsible
for the confusion of the effects of vascular tone in vivo (Black et al., 2001). Despite the effects
of nicotine on basal vascular tone remaining unclear, nicotine is only a fraction of the
constituent compounds in E-cigarette vapor and further study to determine the effects of
commercially available E-cigarette vapor is justified.

1.7 Factors Influencing Peripheral Vascular Tone and Potential Effects of E-cigarettes.
Peripheral arterioles in the skeletal muscle, and more specifically their diameter, can be used as
a measure of the amount of blood flow to the muscle. The diameter of a vessel is proportional
to the force exerted by the smooth muscle and is often referred to as “vessel tone”. Second
order arterioles (2A’s) are generally used for measuring blood flow to an organ or muscle as
they are downstream of major resistance arterioles, though they do provide some resistance
(Bearden, Payne, Chisty, & Segal, 2004). There are several potential effects of E-cigarettes on
the 2A’s including: acute and chronic effects on the endothelium, stimulation of arachidonic
acid pathway metabolites, the NO pathway, the actions of endothelin-1, the renin/angiotensin
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system and sympathomimetic effects of vapor constituents. For the sake of clarity, each of
these potential effects will be discussed separately in their own subsection.
1.7.1 Effects on the Endothelium. Endothelial cells, which line the lumen of the
vasculature have emerged as important potential therapeutic targets, in large part due to their
production of NO. NO plays a role in maintaining vessel diameter as well as in anticoagulation,
leukocyte adhesion and proliferation of vascular smooth muscle cells (Gewaltig & Kojd, 2002).
NO also plays a role in antioxidant capacity, partly because the NO molecule is itself a free
radical which allows it to rapidly pair with any unpaired electrons in circulation (Jeremy et al.,
2002). It is possible that an increase in free radicals associated with E-cig usage can sequester
available NO in the vasculature and effect vessel tone acutely. These acute effects may also be
compounded by chronic use as E-cig liquid extracts have been shown to be toxic to endothelial
cells in culture and may cause apoptosis of endothelial cells via an oxidative mechanism
(Anderson et al., 2016).
1.7.2 Effects of the Arachidonic Acid Pathway. Metabolites of the arachidonic acid
pathway, specifically those derived from the cyclo-oxygenase (COX) reactions may also play a
role in the tone of peripheral arterioles. Arachidonic acid is released by phospholipase A2
where it can be acted on by the COX enzymes to produce cycloendoperoxides which are then
acted on by tissue specific enzymes (Weksler, 1981). Platelets are known to produces
thromboxanes, whereas the endothelium produces prostacyclin and the vascular smooth
muscle produces prostaglandins (Félétou, Huang, & Vanhoutte, 2011). It is important to note
that while prostaglandins and prostaclyclins are considered vasodilatory, thromboxanes are
potent vasoconstrictors that are produced by aggregating platelets (Neppl et al., 2009). Platelet
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aggregation is known to occur in pulmonary injury models and is also important in the
production of thrombospondin-1 (TSP-1), which has been shown to attenuate the actions of the
endothelium after particulate matter inhalation (Mandler, Nurkiewicz, Porter, Kelley, & Olfert,
2018a)
The arachidonic acid pathway is also important in immune responses, COX-2 activity is
associated with inflammatory conditions and has been shown to suppress the activity of several
immune cells (most notably T cells and NK cells) (Liu, Qu, & Yan, 2015). The products of COX-2
may be responsible for alterations of vascular tone acutely and chronically may contribute to
the dampened actions of the immune system in the lungs and airways of E-cigarette users.
1.7.3 Effects of Thrombospondin-1 and its Receptor CD47. TSP-1 can be produced by
most cells in the body, but is a major secretory product found in alpha-granules of aggregating
platelets and secreted during pulmonary injury. Studies have shown that the TSP-1 receptor
CD47 mediates can mediate its effects on the peripheral vasculature (Mandler, Nurkiewicz,
Porter, Kelley, & Olfert, 2018b). In the context of E-cigarettes, it is possible that particulate
matter deposited in the lungs (Manigrasso, Buonanno, Stabile, Morawska, & Avino, 2015)
stimulates platelet aggregation and therefore TSP-1 secretion following acute exposure to Ecigarette vapor. In situations in which TSP-1 is chronically elevated it has been shown to
stimulate vascular smooth muscle proliferation, inhibit endothelial cell proliferation and
activate MMP enzymes which may also contribute to vascular dysfunction (Lawler, 2002).
Currently there is no published data concerning acute E-cigarette exposure and the TSP-1/CD47
axis, however data indicating vascular dysfunction upon E-cigarette exposure (Anderson et al.,
2016; Lehr, 2000) indicates further study into this mechanism is warranted.
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1.7.4 Effects of Endothelin-1. Endothelin-1 is another potentially important molecule in
the E-cig induced vascular dysfunction mechanism. It is known that increased exposure to free
radicals can upregulate endothelin-1 secretion by vascular endothelial cells, causing long lasting
vasoconstriction (Houde, Desbiens, & D’Orléans-Juste, 2016). Recent data suggests that a
feedback between nitric oxide and endothelin-1 may be a major mechanism of myoendothelial
coupling and therefore arteriolar diameter (Hilgers & De Mey, 2009). Endothelin-1 transcription
levels are the primary means of regulation of expression, edn-1 transcription (the gene that
codes for endothelin-1) has been found to be upregulated in hypoxia (Stow, Jacobs, Wingo, &
Cain, 2011). This upregulation in expression has been shown to be inhibited by dilazep
(Shrestha et al., 2004). In the context of E-cigarette use, it is possible that insult to the lungs
may increase edn-1 transcription and therefore endothelin-1 levels, thereby causing systemic
vasoconstriction, increased vascular smooth muscle cell proliferation and decreased endothelial
cell proliferation. This mechanism may also play a role in decreased endothelial-dependent
dilation with chronic exposure to E-cigarettes (Olfert et al., 2018).
This mechanism is of interest as expression of endothelin-1 has been shown to increase
upon inhalation of particulate matter smaller than 2.5 µm in diameter (Brook et al., 2002), and
chronic elevation of endothelin-1 has been shown to be linked to increased rates of
cardiovascular events (Brook et al., 2002). Recent data characterizing the particulate matter
inhaled by E-cigarette users shows that average particulate diameter is between 250-450 nm
(Ingebrethsen et al., 2012), within range to elicit the response of the endothelin-1 pathway.
This mechanism is likely important in evaluating the long-term safety of E-cigarette use and
further research is warranted to characterize the response.
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1.7.5 Effects of the Renin/Angiotensin System. In physiological conditions the reninangiotensin system plays a role in maintaining fluid balance, preventing dehydration and ion
imbalances. In pathological conditions however, overactivation of the renin-angiotensin system
has been shown to cause hypertension (Madhur et al., 2010), superoxide production (Jaimes,
Galceran, & Raij, 1998) and as an activator of NF-κB (Mezzano et al., 2001). These effects are
caused by the product of the renin angiotensin pathway, angiotensin II. Banday et al. have
shown that oxidative stress and the renin-angiotensin system can upregulate each other
causing chronic hypertension and upregulation of inflammatory cytokines (Banday &
Lokhandwala, 2008).
The mechanism underlying how oxidative stress and angiotensin II induced
hypertension is unclear. Data does, however, show that in situations in which angiotensin II is
chronically elevated, the kidneys express higher levels of angiotensin II receptor, and therefore
an exaggerated response to angiotensin II secretion is observed (Banday & Lokhandwala, 2008).
This response leads to an increase in sodium retention (Beltowski, Wójcicka, Marciniak, &
Jamroz, 2004) which is likely to further exacerbate the hypertension as well as contribute to
oxidative stress.
Cigarette smoking has been shown to increase expression of angiotensin II as well as
angiotensin converting enzyme in the lungs (Yuan et al., 2015). The effects of E-cigarettes in this
context have yet to be evaluated but known increases in oxidative stress upon exposure to Ecigarette vapor and the likelihood of interplay with the renin-angiotensin system warrants
further research.
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1.7.6 Potential Sympathomimetic Effects of Vapor Constituents. Another potentially
relevant mechanism of E-cigarettes effecting vascular tone is sympathomimetic effects of
nicotine or other vapor constituents. While it is known that nicotine is sympathomimetic
(Chiou, Trzeciakowski, & Klein, 1976), there is no scientific consensus concerning the effects of
other constituents of E-cigarette liquid on the autonomic nervous system. Human E-cigarette
exposure studies by Moheimani et al. showed that heart rate variability during an exercise test
(a measure of sympathetic activation) was only significantly elevated in subjects exposed to Ecigarette vapor containing nicotine (Moheimani et al., 2017). This means that while vascular
tone may be altered by E-cigarettes through the other mechanisms listed above, sympathetic
activation caused by nicotine may exacerbate these effects. Other constituents of E-cigarette
vapor are not likely to alter tone through this mechanism, but further work is needed in this
area to better understand what biological effects the individual components of E-cigarette
vapor have toward health and disease.
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Chapter 2: Specific Aims
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Tobacco use is widely considered the single greatest risk factor for preventable disease
and death in the developed world(Center for Disease Control and Prevention, 2011). Effects of
tobacco smoke and nicotine, the main addictive component of tobacco, have been extensively
characterized. Electronic cigarettes (E-cigarettes) are among the fastest growing tobacco
products worldwide, especially among users aged 16-26 (Leventhal et al., 2015). E-cigs work by
heating a mixture of propylene glycol, glycerin, flavoring and often nicotine with an atomizer
and allowing the user to inhale the aerosol. It is not surprising that E-cigarettes are increasing
popularity as marketing attempts to portray E-cigarettes as “safe” alternatives to cigarettes,
however scientific and clinical evaluations about the acute and chronic effects from using Ecigarettes are still poorly understood.
Cigarette smoking has also been known to be linked to pathogenesis of cardiovascular
disease (CVD) (Smoking & Disease, 2018), this progression is known to occur through
inflammatory mechanisms. CVD development is in part due to the toxicity of cigarette smoke to
endothelial cells (Giunzioni et al., 2014; Lehr, 2000). While cell culture and ex vivo studies have
demonstrated an inflammatory response of neutrophils (Reidel et al., 2010; Higham et al.,
2016) and decreased aortic endothelial dependent relaxation (Olfert et al., 2018) in response to
E-cig vapor, there is little data detailing the response of the vasculature to E-cigarette exposure
in vivo.
The inflammatory response to cigarette smoke has been well characterized; the immune
system mediates this response through the release of proinflammatory cytokines (“Cigarette
smoke extract induced cytokine and chemokine,” n.d.). Studies detailing the immune response
to E-cigs have mostly focused on isolated cells. These studies have found a significant decrease
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in cellular antioxidant defenses and DNA damage (Ganapathy et al., 2017), increased rates of
viral infection (Wu et al., 2014) and cell death in vascular endothelial cells (Anderson et al.,
2016). The results of these studies indicate a need for further study on the effects of
inflammatory cytokine expression in potentially vulnerable tissues.
Vascular tone is determined by the complex interaction of factors that cause vascular
smooth muscle to contract or relax (Félétou et al., 2011; Neppl et al., 2009). Several factors can
regulate vascular tone, including by altering the bioavailability of nitric oxide (Beckman &
Koppenol, 1996; Jeremy et al., 2002). The immune system is capable of causing oxidative stress
on the endothelial cells that line the luminal surface of the vasculature and produce nitric oxide
(Kuzkaya et al., 2003). Other vascular responses to particulate matter may cause acute
alterations in vessel tone and may be chronically toxic to the cardiovascular system (Brook et
al., 2002).
This study aims to address increase knowledge of how acute E-cigarette exposure alters
peripheral vascular tone, and how chronic exposure may alter the expression of proinflammatory cytokines in potentially vulnerable tissues.

Specific Aim 1: Determine the in vivo effects of acute E-cigarette exposure on vascular
tone in the gluteus maximus vasculature.
Our hypothesis is that E-cigarette exposure will decrease vessel diameter through
decreased nitric oxide production or increased stimulation of vascular smooth muscle
cells to increase vessel tone.
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Specific Aim2: Determine the effects of chronic E-cigarettes exposure on cytokine
expression in various tissues.
Our hypothesis is that chronic E-cigarette exposure increases the concentration of proinflammatory cytokines.
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Chapter 3: Methods
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C57BL/6 mice were used for all experiments (Jackson Laboratories, Bar Harbor ME.).
Mice were housed in a temperature and humidity-controlled vivarium with a 12-hour light/dark
cycle and ad libitum access to standard rodent diet chow and tap water. All experiments were
approved by and conducted in accordance with the guidelines of the West Virginia University
Institutional Animal Care and Use Committee.
3.1 Intravital surgery prep
Mice were anesthetized with intraperitoneal injections of Thiobutabarbital (Inactin, 100
mg/kg) using a 1ml syringe and a 27-gauge needle. Anesthesia was administered via 3 doses
with approximately 20 minutes between doses. Assessment of adequate anesthesia was
performed by toe pinch. During anesthesia period a heat lamp was used to prevent
hypothermia.
After anesthesia was determined to be adequate an endotracheal tube (polyethylene
PE90 tubing approximately an inch long) was inserted via tracheostomy and secured with
suture (Figure 3.1A). The incision made during tracheostomy was sutured shut to prevent
insensible fluid loss and to further secure the endotracheal tube in place. Endotracheal tube
was trimmed to below chin length to mimic anatomical dead space
After successful placement of the endotracheal tube an incision just lateral to the dorsal
midline (Figure 3.1B) was made to visualize the gluteus maximus tendon, the gluteus muscle
was then exposed by further incisions to the skin around the hindlimb. After the gluteus
maximus muscle was exposed it was kept moist with normal saline applied as needed
throughout the prep. Vannas scissors were used to make an incision into the gluteus tendon
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Figure 3.1 Legend: A) Tracheostomy in an anesthetized mouse, B) Incision site for
exteriorization of the gluteus maximus muscle for IVM procedure. Images courtesy of
W. Kyle Mandler, PhD.

and the gluteus maximus was separated from the gluteus medius by spreading the two apart
with the blunt edges of the vannas blades.
Further incisions to the gluteus maximus muscle were used to visualize the vasculature
within the muscle, after a sufficient portion of the muscle was trimmed away from the tendon a
suture was tied using a double loop to prevent tying from clamping the muscle (Figure 3.2).
Traction was applied to the muscle and then the superior and inferior edges of the muscle were
trimmed away using the traction to facilitate separating the gluteus maximus from the gluteus
medius (Figure 3.2). Avoiding damage to the neurovascular plexuses on the superior and
inferior edges of the muscle is imperative as cutting those vessels may result in the death of the
animal.
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Superior and inferior sutures were tied in the same manner as the first tie and the
muscle was then incubated in a heated bath of physiological saline solution that was sealed
with stopcock grease. Compressed gas (5% carbon dioxide, balance nitrogen) was bubbled
through the physiological saline to more closely mimic the interstitial fluid. Heart rate, body
temperature and bath temperature were monitored throughout, and additional anesthesia was
given when necessary.
A water immersion microscope was used to visualize a second-order arteriole in the
exposed gluteus maximus. A heated stage was used to maintain body temperature, which was
monitored and automatically regulated using rectal probe. Fluid was replenished in the bath at

Figure 3.2. Approximately 1 cm Externalized portion of the gluteus maximus muscle in
an anesthetized mouse. Submerged in a 4.5 cm diameter physiological saline solution
bath. Note the double loop knot in the suture preventing the suture from applying
pressure to the muscle. Image courtesy of W. Kyle Mandler, PhD.
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a rate of 4 ml/min to maintain fresh bath environment and temperature. Two separate series of
were performed, 1) two-hour time course evaluation, and 2) shorter (50-min) time course
which included vascular reactivity assessments to varying vasodilation (i.e. acytelcholine)
stimulation.
3.1.1. Intravital Study 1: The first invtravital experiments were to determine the effects
of acute E-cigarette exposure on the peripheral vasculature mice for the longest time possible
(~2hours) while anesthetized under intravital microscopy. A baseline image of the vessel was
taken for comparison post exposure. Before exposure, vasodilatory response to 1x10-3 molar
acetylcholine was also performed by adding the drug to the bath and incubating for 5 minutes.
Acetylcholine was washed out and vessels returned to baseline before exposure occurred.
Thereafter, the animal was exposed to vapor for 5 minutes (5 second puffs, 55 ml puff volume,
30 seconds apart for a total of 10 puffs), or to the smoke of one 3R4F reference cigarette (Univ.
of Kentucky). Mice were exposed to commercially available French vanilla flavored E-cigarette
vapor (containing either 0 or 18 mg/ml of nicotine) (VG/PG-0 and VG/PG-18, respectively), 3R4F
reference cigarette, 100% vegetable glycerin (no nicotine) (VG-0), or 100% propylene glycol (no
nicotine) (PG-0) using a rodent ventilator and tubing to deliver to the smoke/vapor to the
endotracheal tube. An untreated (sham) group underwent the same intravital prep but was not
exposed to any smoke or vapor treatment.
After exposure, images of the vasculature were taken in 15-minute intervals for up to
120 minutes (or until the animal died). These images were then measured using ImageJ
software (NIH), scale was set using measurements from a micrometer and was equal to 300

33

pixels = 100uM. Data was plotted in terms of both absolute vessel diameter and percent change
from baseline.
3.1.2. Intravital Study 2. A second series of studies were conducted to obtain better
time resolution of acute vascular response within 1-hour of exposure and to determine if the
endothelium-dependent dilation capacity of second-order arterioles was impaired by acute
exposure to E-cigarette vapor. After baseline was assessed, a 3-point acetylcholine dilation
curve was obtained (10-7, 10-5 and 10-3 M ACh). Acetylcholine was placed in the bath for 5minute intervals with images taken at the end of each interval.
After the end of the first acetylcholine curve animals were exposed VG/PG-0, VG/PG-18
3R4F reference cigarette, or PG-0 using a rodent ventilator and tubing to deliver to the
smoke/vapor to the endotracheal tube. Images of the vessel were taken in 10-minute intervals
for 50 minutes
After the 50-minute incubation, a second identical acetylcholine dose response curve
was obtained. Dilatory capacity was assessed by measuring vessel diameter with ImageJ
calibrated to measurements from a micrometer. Data was plotted in terms of absolute
diameter and percent change from baseline. A timeline of the second surgical series is provided
below for the sake of clarity (Figure 3.3).
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Figure 3.3 Timeline in minutes showing order of procedures in Study 2. 0 minutes represents
time at which animal was determined to be adequately anesthetized for the procedure.
Microscope icon represents the time at which the animal was placed under microscope and
externalize portion of muscle was placed in the physiological saline bath.

Cytokine Analysis Experiments.
Ten-week old female C57BL6/J mice (n=45, purchased from Jackson laboratory, Bar
Harbor, ME Stock #000664) and randomly assigned to be exposed to either 3R4F reference
cigarette (University of Kentucky, http://www.ca.eky.edu/refcig), commercially available
cappuccino flavored E-cigarette vapor (18mg/ml of nicotine 50% propylene glycol:50%
vegetable glycerin base liquid ratio) or compressed room air (n=15 per group). Mice were
acclimatized to the new facilities for one week before start of exposures, and group housed by
treatment (E-cigarette exposed mice were only housed with other E-cigarette exposed mice,
etc.). Facility conditions were kept constant throughout the exposure period and included a 12h light/dark cycle, 22 ± 4°C temperature, and 39 ± 6% relative humidity. Mice were given access
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to ad libitum tap water and standard rodent chow (18% fat, 24% protein, 58% CHO; Teklad Diet,
Madison, WI). Cage bedding was changed on a bi-weekly basis and injuries (as a result of
fighting, etc.) were treated upon consultation of vet staff.
Mice exposed to E-cigarette vapor and cigarette smoke were exposed using separate,
but identical 15.1-liter whole body exposure chambers. Vapor and smoke were generated using
separate but identical small animal ventilators (HARVARD APPARATUS Dual Phase Control
Respirator, Model 55-0715, South Natick, Massachusetts). Vapor was generated using a
custom-built E-cigarette cradle (SONGLE, Dr. Powsiri Klinkhachorn, Dept. of Electrical
Engineering, West Virginia University, Morgantown, WV) that allowed for precise 5-second
puffs every 99 seconds (for a total of 38-39 puffs per hour) and a commercially available “tank
style” E-cigarette device with voltage set at 4.8 V (eGrip™OLED, Joyetch, ShenZhen, China,
www.joyetch.com). Smoke was generated by inserting and lighting one cigarette every 10
minutes into the ventilator (6 cigarettes per hour). Animals were acclimatized to the smoking
protocols by smoking 1 hour per day the first week of exposure, then adding an hour per day
each week until 4 hours per day was reached.
After the acclimatization period, animals were exposed simultaneously in separate
chambers for 4 hours per day 5 days per week for a total of 8 months. At the end of the 8month exposure period animals were given 24 hours of no exposure and fasted for 8 hours.
Animals were then anesthetized with intraperitoneal ketamine/xylazine. Blood was collected
from a left ventricular puncture and flash frozen then stored at -80°C for later analysis. Other
major organs including brain, lung, and gastrocnemius muscle were dissected and flash frozen
the stored at -80°C. Bronchoalveolar lavage was also performed and fluid was saved, flash
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frozen and stored at -80°C. Homogenates of brain, lung and gastrocnemius were made using a
tris-based buffer. A Meso-Scale Discovery (MSD) U-plex kit (Meso-Scale Discovery Rockville,
Maryland) was run according to manufacturer’s instructions (cytokines tested included: VEGF,
IL-4, IL-5, IL-6, IL1B, IL-15, IL-10, interferon-gamma, granulocyte-macrophage colony stimulating
factor and TNF- α). Results are shown below.

Statistical Analyses
Repeated measures (rANOVA) was used when more than one measurement of the same
variable was obtained in the same animal. If a significant main effect for either exposure or
time was found using rANOVA, Students t-test was used to determine differences by time point
or between groups. In cases of single measurements, ANOVA was used to determine significant
main effects between exposure groups, and if a main effect was observed Fisher’s post-hoc
testing was used to determine significance between groups.
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Chapter 4: Results
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Study 1: 2-hour time course
Shown in Table 1 are body mass, age of the mice at sacrifice in each respective group
and sex of animals used in this study.
Body Mass
Sham
22.0 ± 1.7 g
E-Cig
22.0 ± 0.8 g
3R4F
23.5 ± 0.5 g
Data are presented as mean ± standard error.

Age
90 ± 11 days
89 ± 3 days
85 ± 1 days

Sex (% Male)
33%
42%
100%

Blood vessel diameter was monitored using intravital microscopy for up to 2 hours after
exposures. Vessel responses are plotted in terms of absolute diameter, and as a percentage of
pre-exposure diameter (baseline). Repeated-measures ANOVA show that E-cigarette vapor
(independent of nicotine content) and 3R4F reference cigarettes shows similar decrease in
diameter over time (rANOVA P< 0.05 for absolute diameter and rANOVA p< 0.01 for diameter
with respect to baseline) with both significantly different from sham control groups (Figure 4.1).
Further investigation using the 2-hour time course paradigm showed that VG/PG-0,
VG/PG-18PG-0, VG-0 and 3R4F reference cigarette also yield similar changes over time. Data
were plotted as vessel diameters and with respect to baseline and rANOVA yielded statistically
significant treatment x time interactions in both cases (P<0.05 for both). These results are
shown in Figure 4.2
There were significant differences in male and female animals’ body weights (ANOVA
P<0.05) and baseline vessel diameter (P<0.05). There was not however, a significant sex by time
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interaction, or significant differences in clinical data such as heart rate, body temperature or
bath temperature (P=N.S. for all).
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Study 1: Two-hour Time Course
Tobacco cigarette (3R4F) vs. Electronic Cigarette

A

B

rANOVA Time x Exposure P < 0.05

rANOVA Time x Exposure P < 0.01

*

Figure 4.1 Time course assessment of 2nd order arteriole vessel diameter in the gluteus
maximus muscle measured under intravital microscopy before and up to 120-minutes post
exposure to traditional tobacco cigarettes (3R4F) versus an electronic cigarette. Vessel
diameters are shown in top panel, and responses normalized to pre-exposure basal diameters
(set to 1.0) are shown in bottom panel. Dotted indicates when 5-minute exposure occurred.
Number of animals in each group is as follows: Sham (n=5), 3R4F (n=2), E-cig (n=19).
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A
rANOVA Time x Exposure P < 0.05

B

rANOVA Time x Exposure P < 0.05

*

Figure 4.2 Time course assessment of 2nd order arteriole vessel diameter in the gluteus
maximus muscle measured under intravital microscopy before and up to 120-minutes post
exposure electronic cigarettes using different e-liquid composition and nicotine (i.e., PG-0,
100% propylene glycol with 0 mg nicotine; VG/PG-0, 50% vegetable glycerin:50% PG with 0 mg
nicotine; VG/PG-18, 50:50 VG/PG with 18 mg/ml nicotine). Vessel diameters are shown in top
panel, and responses normalized to pre-exposure basal diameters (set to 1.0) are shown in
bottom panel. Tobacco cigarette (3R4F) shown for reference. Dotted indicates when 5-minute
exposure occurred. Numbers of animals in each group were as follows Sham (n=5), PG-0 (n=3),
VG-0 (n=3), VG/PG-0 (n=5), VG/PG-18 (n=8) and 3R4F (n=2).
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Study 1: Two-hour Time Course
Pre-exposure baseline

30-minutes post exposure

Sham

3R4F

VG/PG-18

Figure 4.3 shows the response of second order arterioles to inhalation exposures in the gluteus
maximus muscle of mice. Pictures on the left are pre-exposure baseline images and pictures on
the right are the same vessels 30 minutes after exposure. Average diameter (from 3
measurements) is shown on the image.
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Study 2: Vascular Reactivity after 50-Minutes following Vaping
Shown in Table 2, are body mass, age at time of sacrifice, and sex of animals used in this
study.

Sham
3R4F
PG-0
VG/PG

Weight
24.3 ± .7 g
25.5 ± .6 g
22.8± 1.3 g
25.6 ± .3 g

Age
84 ± 2 days
101 ± 5 days
102 ± 1 days
97 ± 3 days

% male
100
100
50
100

Data presented as mean ± standard error

Vessel diameters were plotted in terms of absolute vessel diameter and as a percentage
of baseline. rANOVA analysis showed a tendency for time x exposure interaction in absolute
diameter analysis (P=0.10) and a statistically significant time x exposure interaction with
respect to baseline (P<0.05). These data are presented graphically in Figure 4.3.
Vascular reactivity assessment showed no significant impairment in endotheliumdependent dilation with exposure to 3R4F reference cigarettes (Figure 4.4 A and B). The slopes
of dilation curves after exposure to 3R4F cigarettes were also not statistically significantly
different. No significant endothelial impairment was observed with VG/PG-0 orPG-0. However,
VG/PG-18 was found to have a greater slope after exposure (ANOVA P<0.05; Figure 4.4).
Analysis of heart rate, by comparing minimum and maximum recorded values, showed
no statistical difference between groups. Body temperature analysis also showed no statistical
differences between groups. Bath temperature delta value (maximum minus minimum) analysis
shows a statistically significant increase in bath temperature variance (ANOVA P<0.05).
Principally due to greater pre-exposure differences in bath temp in VG/PG groups. Animals
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exposed to E-cigarette vapor (VG/VG) experienced an average bath temperature delta value of
2.6 ± .4 °C, compared to 1.7 ± 0.2 in animals exposed to PG-0, 0.9 ± 0.4 in animals exposed to
3R4F reference cigarettes and 1.0 ± 0.2 in sham animals (figure 4.5).
There were significant differences between male and female animals’ vessel diameters
and body weights (ANOVA P<0.05 for both). But there were no sex x time interactions in terms
of vessel response. There were also no significant differences in clinical variables such as heart
rate, body temperature or bath temperature (P= N.S. for both).
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Study 2: 50-min Time Course
Electronic Cigarette using different E-liquids
rANOVA Time x Exposure P=0.10

A

B
rANOVA Time x Exposure P < 0.05

*

Figure 4.3 Basal diameters of second-order arterioles in the gluteus maximus muscle before
and up to 50-minutes post exposure to tobacco cigarettes (3R4F) and E-cigarette using different
e-liquid composition and nicotine (i.e., PG-0, 100% propylene glycol with 0mg nicotine; VG/PG0, 50% vegetable glycerin:50% PG with 0mg nicotine; VG/PG-18, 50:50 VG/PG with 18mg/ml
nicotine). Absolute vessel diameters (top) and normalized diameters to pre-exposure (bottom
panel). Dotted line indicates when 5-minute exposure occurred. Numbers of animals in each
group were as follows: Sham (n=3), PG-0 (n=6), VG/PG-0 (n=3), VG/PG-18 (n=4) and 3R4F (n=5).
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Study 2: Vascular Reactivity to Acetylcholine (ACh)

Figure 4.4 Vascular reactivity to increasing acetylcholine (ACh) concentration of Pre and 1-hour
Post exposure to traditional tobacco cigarette (3R4F, shown in A and B) and electronic
cigarettes (shown in C and D) with differing e-liquid composition and nicotine (i.e., PG-0, 100%
propylene glycol with 0 mg nicotine; VG/PG-0, 50% vegetable glycerin:50% PG with 0 mg
nicotine; VG/PG-18, 50:50 VG/PG with 18 mg/ml nicotine). A & C show vessel diameters
obtained from 2nd order arterioles in the gluteus maximus muscle under intravital microscopy.
B & D show responses normalized to baseline diameters (set to 1.0). Numbers of animals in
each group were as follows: Sham (n=3), PG-0 (n=6), VG/PG-0 (n=3), VG/PG-18 (n=4) and 3R4F
(n=5).
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Figure 4.5 Heart rate (top), body temperature (middle) and intravital bath temperature
(bottom) measurements obtained during Study 2 data collection. PG-0, 100% propylene glycol
with 0 mg nicotine; VG/PG-0, 50% vegetable glycerin:50% PG with 0 mg nicotine; VG/PG-18,
50:50 VG/PG with 18 mg/ml nicotine; C, degrees Celsius. Numbers of animals in each group
were as follows: Sham (n=3), PG-0 (n=6), VG/PG-0 (n=3), VG/PG-18 (n=4) and 3R4F (n=5).
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Study 3: Chronic Exposure and cytokine analysis
After cytokine assays were run, ANOVA was used to determine if statistical significance
existed between groups. The P-values of each ANOVA are shown in Table 4.1. Statistically
significant changes and tendencies were plotted in Figure 4.6. IL-6 content in the serum of
groups was found to be statistically significant (P<0.05) with air exposed animals expressing
3.535 ± 0.917 pg/ml, 3R4F exposed animals expressing 0.926 ± 0.273 pg/ml and E-cigarette
exposed animals expressing 1.503 ± 0.658 pg/ml. Analysis of VEGF and GM-CSF contained data
from 6 animals per group IL-6 analysis in the serum contained data from 8 air exposed animals,
7 3R4F exposed animals and 9 E-cigarette exposed animals.
While not statistically significant, VEGF content tended to be different in the lungs
(ANOVA P= 0.059) with air exposed animals expressing 8.266 ± 0.866 pg/ml, 3R4F exposed
animals expressing 7.966 ±1.366 pg/ml and E-cigarette exposed animals expressing 4.455 ±
1.156 pg/ml. Bronchoalveolar lavage fluid (BALF) also tended to be different among groups
(ANOVA P= 0.06) with air exposed animals expressing 0.418 ±0.066 pg/ml, 3R4F exposed
animals expressing 0.563 ± 0.062 pg/ml, and E-cigarette exposed animals expressing 0.07 ± 0.0
pg/ml. GM-CSF expression in the lungs tended to be different between groups with air exposed
animals expressing 0.07 ±0.01 pg/ml, 3R4F exposed animals expressing 0.13 ± 0.04 pg/ml and Ecigarette exposed animals expressing 0.04 ± 0.01 pg/ml. These results are presented
graphically in Figure 4.6.
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Study 3: Chronic exposure to E-Cigarette Vapor

ANOVA Exposure Effect P-values for All Cytokines
Lung

Gastrocnemius

Serum

BALF

VEGF

0.059

0.470

0.934

0.060

TNF-a

0.281

0.666

0.450

0.986

GM-CSF

0.056

0.648

0.446

0.096

IFN-gamma

0.662

0.383

0.625

ISD

IL-1B

0.901

0.405

0.347

0.226

IL-4

0.910

0.181

ISD

ISD

IL-5

0.519

0.484

0.930

0.331

IL-6

0.543

ISD

0.040

ISD

IL-10

0.150

0.101

0.253

0.192

IL-15

0.210

0.698

0.714

ISD

Table 3 shows P-values of ANOVA analysis of cytokine expression in tissues of Mice
chronically exposed to either 3R4F reference cigarette, commercially available Cappuccinoflavored E-liquid (Joyetech, ShenZhen, China) (18 mg/ml nicotine) or filtered room air. Bold
values showed either tendencies (P<0.06) or statistically significant (P<0.05) changes in
cytokine levels. Cells labelled ISD had insufficient data for ANOVA analysis. Cytokines tested
were: vascular endothelial growth factor (VEGF), tumor necrosis factor- alpha (TNF-a),
granulocyte-macrophage colony stimulating factor (GM-CSF), interferon-gamma (IFNgamma) and interleukins (IL) 1B, 4, 5, 6, 10, and 15.
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Figure 4.6 shows expression of cytokines in tissues highlighted in table 4.1 as either a
tendency to be different (VEGF in BALF and lung, as well as GM-CSF in lung) or statistically
different (IL-6 in serum). Data are presented as mean ± standard error. VEGF and GM-CSF
analysis contained 6 animals per group. Number of animals in IL-6 numbers were as follows,
Air (n=8), 3R4F (n=7), E-cig (n=9).
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Chapter 5: Discussion, Limitations and Future Directions
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Discussion
The principal finding of this study is that acute E-cigarette exposure causes peripheral
blood vessel constriction, independent of nicotine, in the gluteus maximus muscle of mice.
These effects are also observed with exposure to either 100% propylene glycol or vegetable
glycerin, suggesting the base constituents of the E-liquid solution may be a key factor initiating
vasoconstriction. Despite causing vasoconstriction, the ability of the endothelium to dilate to a
vasodilatory stimulus (i.e. acetylcholine) remains largely unimpaired 1 hour after a single acute
E-cigarette exposure. When a chronic E-cigarette paradigm is applied (i.e. 8 months of daily
exposure) the expression of growth factors and cytokines are also altered in several tissues,
suggesting altered immune and metabolic function. Taken together, these data show that
alteration in vascular function are similar between E-cigarettes and traditional cigarettes which
calls into question the safety of E-cigarettes and suggests that the long-term effect on blood
vessels with E-cigarette use will likely be similar to those of regular cigarettes.

Acute Time Course Responses
We evaluated the time course response in two separate studies. Our first study
observed the longest timeframe we could, using our intravital microscopy prep (approximately
2 hours). The second study was designed to provide a greater temporal resolution in the
observed vasoconstriction response and determine if endothelial function was impaired. These
series of experiments provide early evidence establishing the concept that acute E-cigarette
exposure alters peripheral vascular tone. Figure 4.2 shows that E-cigarette exposure
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(independent of nicotine content) causes marked peripheral vasoconstriction, to a degree that
mimics a 3R4F reference cigarette. The observed vasoconstriction lasts longer than 120 minutes
post exposure in all cases. Further study will be needed to determine the total amount of time
that vasoconstriction persists, this study is constrained by the survival time under anesthesia of
mice in the prep.
We observed no significant differences in vessel tone when exposing animals to vapor
with or without nicotine, suggesting that other mechanisms are responsible for altered tone
after exposure. Mice were exposed to (nicotine-free) 100% concentrations of either base
component in E-liquid (i.e. PG-0 or VG-0) each produced vasoconstriction that mimics 3R4F
cigarettes (Figure 4.2). Because PG-0 and VG-0 produced similar patterns of vasoconstriction,
vaporizing the two components of the base liquid either, 1) produces similar breakdown
products (i.e. carbonyl compounds), or 2) produces similar doses of particulate matter that
could drive vasoconstriction. Other studies have reported increases in oxidative stress upon
exposure to E-cigarette aerosols and extracts, suggesting that the mechanism of
vasoconstriction we are observing in vivo may be a consequence of increased circulating
reactive oxygen species (ROS) associated with oxidative stress (Anderson et al., 2016; Reidel et
al., 2017; Ganapathy et al., 2017). ROS is known to be present in the vapor of E-cigarettes, as
well as the smoke of traditional cigarettes (Sussan et al., 2015), and known to alter endothelial
cell function in acute and chronic exposure paradigms (Cimmino et al., 2015; M. Kim et al.,
2014).
Inhalation of particulate matter may also be an important factor since it has been shown
to increase expression of endothelin-1 (Brook et al., 2002; Houde et al., 2016). If particulate
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matter is driving vasoconstriction, it is possible that endothelin-1 is involved. Aldehyde
exposure, which is found in E-cigarette vapor, has been linked to cardiopulmonary toxicity
which may involve the actions of TRPA-1 are thought to play a role (Conklin, 2016). One or both
pathways may play a role in the effects of E-cigarettes on the peripheral vasculature.
Another potential mechanism of the vasoconstriction we observe is the TSP-1/CD47
pathway and its action on NO bioavailability. TSP-1 has been shown to be highly expressed in
pulmonary injury (Mandler et al., 2018a). Preliminary data from our lab indicates that CD47
knockout mice (that don’t express the TSP-1 receptor CD47) may, in part, be protected from
vasoconstriction after exposure to E-cigarette vapor (data not shown). This could indicate that
E-cigarettes might increase expression of TSP-1, which in turn could decrease bioavailable NO,
resulting in increased basal vessel tone (or constriction). TSP-1 expression has also been shown
to increase endothelial cell apoptosis (Nör, Mitra, & Sutorik, 2000), chronic periodic elevation of
TSP-1 may also contribute to increased arterial stiffness (through decreased NO bioavailability)
and decreased endothelial response (by increasing endothelial apoptosis)(Nör et al., 2000).
Arguing against a NO-mediated mechanism, however, is the observation that endothelial cell
responses to ACh (i.e. vessel reactivity, discussed below) are largely unaffected the time point
we studied (i.e. ~1-hour post exposure).
Neural input may also play a role in our findings, the sympathetic nervous system alters
vascular tone through the effects of norepinephrine (Malpas et al., 2001). Nicotine has also
been shown to decrease the clearance of norepinephrine (Brees et al., 2008). There is also
evidence that particulate matter inhalation (from diesel fuel exhaust) causes activation of the
sympathetic nervous system, the mechanisms here, however, are unclear (Carll et al., 2013). If
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particulate matter drives sympathetic activation, vasoconstriction with exposure to E-cigarettes
should be expected. It would also be expected however that heart rate would increase due to
sympathetic stimulation, which our data does not show.

Vascular Reactivity
The ability of a blood vessel to dilate to acetylcholine is a measure of the ability
endothelium to produce NO. Impaired NO synthesis has been shown to be an early predictor in
the development of CVD (Beckman & Koppenol, 1996; Jeremy et al., 2002). In vivo data in
humans has shown that a single exposure to cigarette smoke impairs endothelium-dependent
dilation (Lekakis et al., 1997). To assess endothelial dilatory capacity, we compared a preexposure acetylcholine dilation response, to identical doses of acetylcholine 50 minutes after
exposure. Figure 4.4 shows that endothelial function was not different between pre- and postexposure dilation curves in either E-cigarettes or traditional cigarettes, except for the VG/PG-18
group. These data, while not in disagreement with previous findings published from our lab that
chronic E-cigarette exposure causes impairment of endothelium-dependent dilation, does
suggest that a single exposure is not enough to cause impaired endothelial cell response to a
vasodilatory stimulus. Data illustrating the endothelial response of humans in response to Ecigarette exposure found significant impairment in ability to dilate 5-minutes post-exposure,
indicating that endothelium impairment caused by a single E-cigarette exposure may be
resolved sooner than 50 minutes (Carnevale et al., 2016), in which case, we would have missed
detecting any impairment at our >50-minute time point. We did, however, observe that
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VG/PG-18 exposure group resulted in greater slope of the acetylcholine curve post exposure.
This may be indicative of a role of nicotine, or some other vapor constituent in sensitizing the
endothelium to acetylcholine. Nicotine may be the most logical factor because none of the
other vapor exposed groups elicited this response, however the slope of 3R4F animals was not
different. This suggests there may be some other factor (other than nicotine) involved. It is also
possible that greater slope post exposure may be an artifact of dilating from a constricted point
to the same diameter. This would mean endothelial function is not impaired, which is
consistent with nicotine having a short half-life (9-10 mins) and therefore not effecting the
endothelium 50-minutes post exposure (Siu & Tyndale, 2007). There was also no verification of
nicotine content in the serum of our mice, it is possible that levels of nicotine from 3R4F versus
E-cigarette (with VG/PG-18) were different.
We monitored clinical variables (i.e. heart rate and body temperature) to evaluate the
physiological stability of animals throughout the procedure. In general heart rate and body
temperature were stable through all groups throughout the procedure, however VG/PG-18
shows a potential activation of the sympathetic nervous system with a sharp post exposure
increase in heart rate. The sympathetic activation is tempting to attribute to nicotine, however
(as mentioned before) since we do not yet know if serum levels of nicotine were the same
between the groups, we cannot know if this was a nicotine mediated effect.
We also monitored bath temperature surrounding the externalized muscle, this
temperature most closely measures the temperature of the micro-vessel environment.
Variability in bath temperature in the pre-exposure portion of the experiment was likely due to
the need of the apparatus used for heating the bath to warm up. While it is possible the lower
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pre-exposure bath temperatures could have influenced the reactivity responses, we would note
that even the groups which has a constant temperature (i.e. sham and PG-0, Figure 4.5)
exhibited no change in slope pre vs. post exposure. This suggests the absolute difference in
temperature we observed in the VG/PG-18 and VG/PG-0 groups (delta temperature ranging
from 0.8 - 1.6 °C) did not likely alter the outcome (i.e. no change in slope for VG/PG-0, and a
steeper slope for VG/PG-18 post exposure). Supporting this notion, a previous study suggests
that temperature differences this small should not greatly influence vessel responses, as
endothelial dysfunction was found to not be impaired even after hypothermic circulatory arrest
with a delta temperature change of 19°C (i.e. from 37 °C to 18 °C) (Cooper et al., 2000). It
should also be noted, the lower absolute temperature of the bath (~35 °C) compared to body
core temperature (37 °C) is also consistent with data frequently obtained during IVM
procedures in peripheral skeletal muscle.
Lastly, our study also found no significant effect of sex on the vascular response to Ecigarette vapor. This is an interesting finding considering the known vaso-protective effects of
estrogen (Collins, 1985). The protective effect of estrogen has, however been shown to
decrease in response to increasing levels of oxidative stress such as exposure to E-cigarette
vapor (Wassmann et al., 2001). This raises concerns about the vaso-protective effects of
estrogen being diminished with chronic E-cigarette use.
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Cytokine Analysis
In prior work, we exposed mice to E-cigarette vapor for 8 months and report a
significant decrease in vascular reactivity to acetylcholine (Olfert et al., 2018). As part of this
project we sought to evaluate the response of pro-inflammatory cytokines and growth factors
in tissues obtained from these mice. The lungs, BALF, serum and gastrocnemius muscle were
chosen as key sites likely to be affected by vaping.
The only significant finding we observed was a decrease in serum levels of IL-6 in Ecigarette and 3R4F cigarette exposed mice. The levels of IL-6 in E-cigarette exposed mice
behaved more like cigarette animals than air exposed controls. IL-6 has been shown to
contribute to immunity by stimulating immune cell response to pathogens (van der Poll et al.,
1997). Decreases in serum IL-6 may be indicative of lower levels of immune system activity and
contribute to the increased latency and rates of infections described above. IL-6 levels have
been previously linked to the development of cardiovascular disease, as well as insulin
resistance (De Mello et al., 2009). The observed changes in IL-6 with our study are consistent
with these findings, the lack of changes observed with TNF-α is interesting in this context as IL-6
and TNF-α expression changes are generally thought to be concomitant (Azzolina, Bongiovanni,
& Lampiasi, 2003; De Mello et al., 2009). Other studies have shown increases in TNF-α in
response to cigarette smoke and E-cigarette exposure ( Reidel. et al., 2017; Reidel et al., 2010).
VEGF levels tended to be lower in both lungs and BAL fluid, the role of VEGF in
angiogenesis has been extensively characterized (Carvalho, Blank, & Shoenfeld, 2007; Mayer et
al., 2005). VEGF has been shown to play a role in vascular permeability, which may precede
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pulmonary inflammation in asthma patients (Khor et al., 2009). VEGF has also been shown to
exert anti-apoptotic effects (Štefanec, 2000). Decreases in lung VEGF may indicate an increase
in endothelial apoptosis. VEGF has also been linked to altering vascular permeability, a concern
in the development of asthma (Khor et al., 2009). Asthma has been raised as a possible concern
with chronic E-cigarette use by other groups (Higham et al., 2016), these results support that
notion. further research will be needed to determine if the tendency observed in this study is
physiologically significant.
GM-CSF in the lungs also tended to be different among groups, E-cigarette exposed
animals showed lower concentrations of GM-CSF than cigarette exposed animals. High levels of
GM-CSF have been attributed to the development of COPD phenotype in the past (Botelho et
al., 2011). This may hint at COPD developing by different mechanisms with cigarette and Ecigarette use, but more research will be needed to determine if that is the case. The effects of
GM-CSF on the peripheral vasculature are unclear and further research will be needed to
determine the implications of this observation.

Limitations
A major concern surrounding all E-cigarette research is the highly variable way to use Ecigarettes, from the composition of liquids, temperature, voltage and puff topography. The
exposure paradigm used in the acute studies (10 puffs, 5 second puff duration, 30 seconds
apart) was meant to mimic the nicotine content of a single cigarette (Farsalinos, Spyrou, et al.,
2015). In the chronic study we attempted to match for time and total particulate matter (TPM)
60

exposure. Changing exposures may alter outcomes that we observe, but it should be noted that
our exposure is light compared to that typically used in smoking-related studies. This means
that, even at low levels of exposure, chronic E-cigarette use is likely to have significant effects
toward cardiovascular health, suggesting that there may no real safe level of exposure.
Current generations of E-cigarettes allow for custom settings of power applied (i.e.
watts, voltage) and temperature. In our study, we controlled the watts of the E-cigarette
device, but the results are likely to vary if one uses different wattage or voltage (especially in
chronic exposures). The flavor of the E-cigarette liquids is another variable that could have
great influence on the presence of chemical breakdown products in the vapor created, not to
mention that the settings of E-cigarette device may also alter the breakdown products of in the
flavorings, resulting in a complex and potentially highly variable vapor composition. While it is
not practical to test every combination, our data used both flavorings (i.e. VG/PG-18 and
VG/PG-0) vs. no flavorings (i.e. PG-0 and VG-0) will little difference between the observed
results. Thus, at least from a vascular response perspective (i.e. base tone and reactivity to
stimulus), it would appear that French Vanilla flavoring had no additional effects. This does not,
however, preclude the possibility that other combinations of either flavors or device settings
might behave differently and produce worse outcomes.
To make in vivo measurements, we had to use a surgical prep under anesthesia. The use
of anesthesia may have had some influence on the vasculature, but all groups were treated the
same and animals served as their own control, therefore the responses we observed are
expected to be qualitatively accurate, even if the heart rate (and other clinical variables) are
quantitatively influenced by anesthesia. Prior studies also support the use of Inactin for IVM
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procedures due to the minimal cardiovascular side effects. The need for mice to be exposed
through the endotracheal tube may have eliminated ancillary parasympathetic input that could
come from flavoring activation on sweet tastes. Parasympathetic input in this context may
counteract the effects of nicotine as a sympathomimetic. While the effects on peripheral
vasculature are not likely to be significantly altered by parasympathetic input, the arteries that
perfuse the digestive tract may be altered.
The biggest limitation, at this point, is the lack of confirmation that nicotine levels were
the same in nicotine treated groups. While we have obtained serum post exposure these
analyses have not yet been carried out. It is possible, that PG/VG-18 or 3R4F exposed animals
received different levels of nicotine and increasing the relative dose of nicotine may increase
the effects (i.e. increases in heart rate).

Future work
The primary focus of E-cigarette research moving forward should focus on how different
alterations of settings and vapor composition on commercially available devices effect human
health. Our studies highlight the implications of E-cigarette vapor on the vasculature with
implications toward the immune system, but other body systems may be affected also. Our
data suggest further research regarding the mechanism of peripheral vasoconstriction is
warranted. There is, indeed, a complex interplay of multiple control systems that ultimately
control vascular and immune cell function and understanding these pathways will allow insight
into treatment options to potentially combat chronic disease.
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Oxidative damage to the endothelium has been a major player in the previous findings
of our lab, and endothelial protection might be accomplished by simultaneous E-cigarette
exposure and antioxidant administration. It would useful to evaluate the NO pathway by
including administration of a nitric oxide synthase inhibitor (i.e. L-NAME) to the microvascular
bed. If vasoconstriction is observed while eNOS is inhibited, then the bioavailability of NO in the
observed vasoconstriction will be called into question. In the event inhibiting eNOS does not
alter changes to vascular tone, administration of antioxidants may provide insight into
mechanism, superoxide for example, may be produced by the breakdown of E-liquid and its
effects on the endothelium may be prevented by administering superoxide dismutase
(Förstermann & Münzel, 2006; Raij et al., 2001). It would also be worthwhile to compare free
radical content (using electron paramagnetic resonance studies) of the E-cigarette vapor and
3R4F reference cigarettes. Understanding the relative exposure to free radicals can give insight
into the oxidative load (and presumably endothelial damage) the animals are exposed to.
If the NO pathway is shown to be unaffected, testing the effects of vasoconstrictor
elements would be a logical next step. Endothelin-1 would be particularly interesting since it is
known to increase in the lung following inhaled exposure to particulate matter. ELISA assays or
western blot techniques could be used to detect circulating levels of endothelin-1 in the serum.
Because endothelin-1 expression is primarily regulated through gene expression real-time PCR
techniques may be used to determine relative levels of gene expression if protein levels of
endothelin-1 are not elevated (Houde et al., 2016; Marasciulo, Montagnani, & Potenza, 2006;
Shrestha et al., 2004). The vasodilatory drug Dilazep works by inhibiting endothelin-1 synthesis,
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administration of dilazep prior to E-cigarette exposure using an intravital approach may provide
insight into the mechanism of vasoconstriction we observe (Shrestha et al., 2004).
More testing of the effects of E-cigarettes on the immune system are needed. Future
work should also focus on the role of neutrophil infiltration in the lungs observed by other
studies. Chronic exposure to E-cigarettes may cause clinically significant impairment in the
lungs if the realistic levels of E-cigarette exposure drives the neutrophil inflammatory response.
This would lead to concerns of the development of COPD with chronic E-cigarette use.
Newer E-cigarette products, that present unique ingredients and therefore vapor
composition, are also beginning to appear on the market. These include vitamin vapes,
cannabidiol vapor products and Juul. The claims of safety surrounding these products mimic
those that surrounded E-cigarettes when they first appeared on the market, these claims are
largely not scientifically validated. Many of these products use the same “base” solution as Ecigarettes. Because the effects of E-cigarettes on the vasculature are independent of nicotine
and seem to be caused by the base solution itself, the outcomes of chronic use of these
products is therefore likely to be similar even though the device system may vary. More studies
are needed in the safety of inhaling the active ingredients of these products, and to the
determine the effects of device settings (i.e. temperature, power, etc.) on producing the
compounds inducing the changes in vascular function.
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